User profiles for Nathalie Auger
Nathalie AugerUniversity of Montreal Verified email at inspq.qc.ca Cited by 6538 |
The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis
Background: The impact of coronavirus disease 2019 (COVID-19) on maternal and newborn
health is unclear. We aimed to evaluate the association between severe acute respiratory …
health is unclear. We aimed to evaluate the association between severe acute respiratory …
High-throughput genomics and clinical outcome in hard-to-treat advanced cancers: results of the MOSCATO 01 trial
High-throughput genomic analyses may improve outcomes in patients with advanced cancers.
MOSCATO 01 is a prospective clinical trial evaluating the clinical benefit of this approach. …
MOSCATO 01 is a prospective clinical trial evaluating the clinical benefit of this approach. …
A new model of patient tumor-derived breast cancer xenografts for preclinical assays
E Marangoni, A Vincent-Salomon, N Auger… - Clinical cancer …, 2007 - AACR
Purpose: To establish a panel of human breast cancer (HBC) xenografts in immunodeficient
mice suitable for pharmacologic preclinical assays. Experimental Design: 200 samples of …
mice suitable for pharmacologic preclinical assays. Experimental Design: 200 samples of …
[PDF][PDF] Detection of Circulating Tumor Cells Harboring a Unique ALK Rearrangement in ALK-Positive Non–Small-Cell Lung Cancer
…, A Barthélémy, M Oulhen, N Auger… - Journal of clinical …, 2013 - researchgate.net
Purpose The diagnostic test for ALK rearrangement in non–small-cell lung cancer (NSCLC)
for crizotinib treatment is currently done on tumor biopsies or fine-needle aspirations. We …
for crizotinib treatment is currently done on tumor biopsies or fine-needle aspirations. We …
[HTML][HTML] Molecular profiling of patient-derived breast cancer xenografts
…, C Guyader, C Decraene, C Lucchesi, N Auger… - Breast cancer …, 2012 - Springer
Introduction Identification of new therapeutic agents for breast cancer (BC) requires preclinical
models that reproduce the molecular characteristics of their respective clinical tumors. In …
models that reproduce the molecular characteristics of their respective clinical tumors. In …
[HTML][HTML] Clinical and translational implications of RET rearrangements in non–small cell lung cancer
Since the discovery in 2012 of rearranged during transfection proto-oncogene gene (RET)
rearrangements in NSCLC, at least 12 different fusion variants have been identified, with …
rearrangements in NSCLC, at least 12 different fusion variants have been identified, with …
Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line features
…, P Saulnier, JG Judde, JL Janneau, N Auger… - Cancer research, 2007 - AACR
Obtaining representative human colon cancer cell lines from fresh tumors is technically difficult.
Using 32 tumor fragments from patients with colon cancer, the present study shows that …
Using 32 tumor fragments from patients with colon cancer, the present study shows that …
[PDF][PDF] Accumulation of segmental alterations determines progression in neuroblastoma
…, G Pierron, V Mosseri, A Valent, N Auger… - Journal of Clinical …, 2010 - researchgate.net
Purpose Neuroblastoma is characterized by two distinct types of genetic profiles, consisting
of either numerical or segmental chromosome alterations. The latter are associated with a …
of either numerical or segmental chromosome alterations. The latter are associated with a …
Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study
…, I Di Mauro, J Rapp, G Pierron, N Auger… - The Lancet …, 2016 - thelancet.com
Background Advances in molecular genetics of sarcoma have enabled the identification of
type-specific aberrations. We aimed to assess the clinical effect of systematic implementation …
type-specific aberrations. We aimed to assess the clinical effect of systematic implementation …
Association between preeclampsia and congenital heart defects
Importance The risk of congenital heart defects in infants of women who had preeclampsia
during pregnancy is poorly understood, despite shared angiogenic pathways in both …
during pregnancy is poorly understood, despite shared angiogenic pathways in both …